Sutro Biopharma
STRO
STRO
119 hedge funds and large institutions have $398M invested in Sutro Biopharma in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 57 increasing their positions, 29 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9.66% less ownership
Funds ownership: 96.58% → 86.92% (-9.7%)
37% less call options, than puts
Call options by funds: $714K | Put options by funds: $1.14M
Holders
119
Holding in Top 10
1
Calls
$714K
Puts
$1.14M
Top Buyers
| 1 | +$14.6M | |
| 2 | +$8.27M | |
| 3 | +$6.88M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.8M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$4.4M |
Top Sellers
| 1 | -$15M | |
| 2 | -$9.44M | |
| 3 | -$8.16M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$7.68M |
| 5 |
Holocene Advisors
New York
|
-$3.97M |